MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis

Transplantation

Volumn 94, Issue 11, 2012, Pages 1086-1094

  Ben Dov, Iddo Z ^a   Muthukumar, Thangamani ^b,c   Morozov, Pavel ^a   Mueller, Franco B ^b   Tuschl, Thomas ^a   Suthanthiran, Manikkam ^b,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Interstitial fibrosis and tubular atrophy; Kidney transplantation; MicroRNA; Next generation sequencing

Indexed keywords

COMPLEMENTARY DNA; MICRORNA; MICRORNA 142 3P; MICRORNA 21; MICRORNA 30A; MICRORNA 30D; MICRORNA 30E; MICRORNA 506; MICRORNA 5P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; EMBRYO; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

ADULT; ATROPHY; BIOPSY; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MICRORNAS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA;

EID: 84871621846     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182751efd     Document Type: Article

References (39)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD 2011.
2. Arias M, Seron D, Moreso F, et al. Chronic renal allograft damage: existing challenges. Transplantation 2011; 91: S4.
3. Nankivell BJ, Chapman Jr. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006; 81: 643.
4. Aravin A, Tuschl T. Identification and characterization of small RNAs involved in RNA silencing. FEBS Lett 2005; 579: 5830.
5. Farazi TA, Horlings HM, Ten Hoeve JJ, et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 2011; 71: 4443.
6. Petillo D, Kort EJ, Anema J, et al. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 2009; 35: 109.
7. Sun H, Li QW, Lv XY, et al. MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol Biol Rep 2010; 37: 2951.
8. Nagalakshmi VK, Ren Q, Pugh MM, et al. Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidney. Kidney Int 2011; 79: 317.
9. Jung M, Schaefer A, Steiner I, et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 2010; 56: 998.
10. Dai Y, Sui W, Lan H, et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009; 29: 749.
11. Saal S, Harvey SJ. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens 2009; 18: 317.
12. Wang G, Kwan BC, Lai FM, et al. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens 2010; 23: 78.
13. Wang G, Kwan BC, Lai FM, et al. Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab Invest 2010; 90: 98.
14. Shan J, Feng L, Luo L, et al. MicroRNAs: potential biomarker in organ transplantation. Transpl Immunol 2011; 24: 210.
15. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009; 106: 5330.
16. Hartono C, Muthukumar T, Suthanthiran M. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010; 15: 35.
17. Sui W, Dai Y, Huang Y, et al. Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transpl Immunol 2008; 19: 81.
18. Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 2011; 157: 191.
19. Anglicheau D, Muthukumar T, Hummel A, et al. Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation 2012; 93: 1136.
20. Blow MJ, Grocock RJ, van Dongen S, et al. RNA editing of human microRNAs. Genome Biol 2006; 7: R27.
21. Kawahara Y, Zinshteyn B, Sethupathy P, et al. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007; 315: 1137.
22. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401.
23. Hafner M, Landthaler M, Burger L, et al. Transcriptome-wide identification of RNA-binding protein and MicroRNA target sites by PAR-CLIP. Cell 2010; 141: 129.
24. Hafner M, Renwick N, Brown M, et al. RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries. RNA 2011; 17: 1697.
25. Neal CS, Michael MZ, Pimlott LK, et al. Circulating MicroRNA expression is reduced in chronic kidney disease. Nephrol Dial Transplant 2011; 26: 3794.
26. Scian MJ, Maluf DG, David KG, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 2011; 11: 2110.
27. Sarver AL. Toward understanding the informatics and statistical aspects of micro-RNA profiling. J Cardiovasc Transl Res 2010; 3: 204.
28. Alon S, Vigneault F, Eminaga S, et al. Barcoding bias in high-throughput multiplex sequencing of miRNA. Genome Res 2011; 21: 1506.
29. Li JH, Zhu HJ, Huang XR, et al. Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002; 13: 1464.
30. Zhong X, Chung AC, Chen HY, et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011; 22: 1668.
31. Jazbutyte V, Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010; 11: 926.
32. Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer. J Pathol 2011; 223: 102.
33. Roy S, Khanna S, Hussain SR, et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009; 82: 21.
34. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibro-blasts. Nature 2008; 456: 980.
35. Yi-Chun J, Nair V, Ju W, et al. MicroRNA-21 and TGF-beta in Diabetic Glomerulopathy. American Society of Nephrology Kidney Week, Vol 22. Philadelphia, PA: Journal of the American Society of Nephrology, supplement; 2011.
36. Hsu SD, Lin FM, Wu WY, et al. miRTarBase: a database curates experimentally validated MicroRNA-target interactions. Nucleic Acids Res 2011; 39: D163.
37. Berninger P, Gaidatzis D, van Nimwegen E, et al. Computational analysis of small RNA cloning data. Methods 2008; 44: 13.
38. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol 2010; 11: R106.
39. Betel D, Wilson M, Gabow A, et al. The MicroRNA.org resource: targets and expression. Nucleic Acids Res 2008; 36: D149.